热门资讯> 正文
Envoy Medical GAAP每股收益为-0.27美元
2024-08-13 22:48
- Envoy Medical press release (NASDAQ:COCH): Q2 GAAP EPS of -$0.27.
- Revenue was $68K compared to $63K for the same period in 2023.
- As of June 30, 2024, the company had cash and cash equivalents of approximately $1.7M
- Shares -4.05%.
More on Envoy Medical
- Envoy Medical Is Pursuing Filling A Hearing Industry Void
- Seeking Alpha’s Quant Rating on Envoy Medical
- Historical earnings data for Envoy Medical
- Financial information for Envoy Medical
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。